Atea Pharmaceuticals, Inc. (AVIR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 3.4200 |
| Open | 3.4400 |
| Bid | 3.1500 x 800 |
| Ask | 3.8900 x 900 |
| Day's range | 3.3300 - 3.4900 |
| 52-week range | 3.1500 - 9.7900 |
| Volume | |
| Avg. volume | 505,508 |
| Market cap | 274.849M |
| Beta (5Y monthly) | 0.17 |
| PE ratio (TTM) | 10.58 |
| EPS (TTM) | 0.3120 |
| Earnings date | 08 May 2023 - 12 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 7.33 |
- Simply Wall St.
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) is a favorite amongst institutional investors who own 62%
Every investor in Atea Pharmaceuticals, Inc. ( NASDAQ:AVIR ) should be aware of the most powerful shareholder groups...
- Simply Wall St.
Atea Pharmaceuticals (NASDAQ:AVIR) shareholders have endured a 42% loss from investing in the stock a year ago
The simplest way to benefit from a rising market is to buy an index fund. Active investors aim to buy stocks that...
- Zacks
Atea Pharmaceuticals, Inc. (AVIR) Moves to Buy: Rationale Behind the Upgrade
Atea Pharmaceuticals, Inc. (AVIR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
© 2023 Yahoo. All rights reserved.
